Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v7-FR
Language English French
Date Updated 2017-04-27 2017-04-26
Drug Identification Number 02394839 02394839
Brand name ESOMEPRAZOLE ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE ESOMEPRAZOLE
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients ESOMEPRAZOLE ESOMEPRAZOLE
Strength(s) 20MG 20MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30 30
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-03-28 2017-03-28
Estimated end date
Actual end date 2017-04-26 2017-04-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments